# Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

> **NCT05272462** · PHASE2 · UNKNOWN · sponsor: **Loyola University** · enrollment: 34 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Minoxidil

## Key facts

- **NCT ID:** NCT05272462
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2023-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05272462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05272462, "Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05272462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*